“德國基因治療工作組”官方機構(gòu)“生物醫(yī)學研究協(xié)會”官方機構(gòu)分子生物學和基因技術(shù)的應(yīng)用提高了對人類疾病的認識，創(chuàng)造了一個新的研究分支——“分子醫(yī)學”。分子醫(yī)學雜志(JMM)出版與人類生物學和病理生理學有關(guān)的所有方面的最高質(zhì)量的原始論文、快速通訊評論文章和通信。基因技術(shù)、基因治療、分子結(jié)構(gòu)分析、遺傳流行病學、分子與臨床藥理學等方面的研究應(yīng)用，在認識人類疾病的預(yù)防、診斷與治療方面，取得了前所未有的進展和精度。因此，分子醫(yī)學的這些領(lǐng)域?qū)⑹艿骄庉嬑瘑T會的特別關(guān)注。描述體外或動物研究的論文，如果與正常或病理的人類生物學有關(guān)，將被接受。請在確認信的末尾附上一份聲明，聲明實驗符合實驗所在國的現(xiàn)行法律。

Official Organ of the "German Working Group for Gene Therapy (DAG-GT)" Official Organ of the "Biomedical Research Association (KBF)" The employment of molecular biology and gene technology has enhanced the understanding of human diseases creating a new branch of research - that of "molecular medicine". The Journal of Molecular Medicine (JMM) publishes original papers rapid communications review articles and correspondence of the highest quality pertinent to all aspects of human biology and pathophysiology. The application of research involving gene technology gene therapy molecular structural analysis genetic epidemiology and molecular and clinical pharmacology has made unprecedented progress and precision possible in the understanding prevention diagnosis and treatment of human diseases. These areas of molecular medicine therefore will be given particular attention by the editorial board. Papers describing in vitro or animal studies will be accepted if they are relevant to normal or pathological human biology. Please include at the end of the acknowledgements a declaration that the experiments comply with the current laws of the country in which the experiments were performed.